Quest Enters Market For BRCA Gene Testing
This article was originally published in The Gray Sheet
Executive Summary
With the Oct. 15 launch of the BRCAvantage genetic test, Quest Diagnostics Inc. became the latest entrant into the now-competitive marketplace for BRCA diagnostic testing for the likelihood of inheriting breast or ovarian cancer.